Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Sayen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Medicine|October 29, 2010
Scrub typhus in Assam and Burma; a clinical study of 616 casesJ J SAYEN, H S POND
Transactions of the American Clinical and Climatological Association|January 1, 1982
Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortalityJ J Sayen, R B Singer, G Peirce, et al.
Transactions of the American Clinical and Climatological Association|January 1, 1992
Heparin for oral use: preliminary studiesO Horwitz, W T Johnson, J J Sayen, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Medicine|October 29, 2010
Scrub typhus in Assam and Burma; a clinical study of 616 casesJ J SAYEN, H S POND
Transactions of the American Clinical and Climatological Association|January 1, 1982
Unstable angina, myocardial infarction, heparin and death: medium dose heparin (not exceeding 20,000 units/day) in the treatment of patients with acute coronary event--first year and long-term comparative mortalityJ J Sayen, R B Singer, G Peirce, et al.
Transactions of the American Clinical and Climatological Association|January 1, 1992
Heparin for oral use: preliminary studiesO Horwitz, W T Johnson, J J Sayen, et al.
Pageof 1